Ticker Details
Taysha Gene Therapies, Inc.
IPO Date:	September 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.29B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 4.12%
Avg Daily Range (30 D):	$0.12 | 2.59%
Avg Daily Range (90 D):	$0.15 | 3.12%

Institutional Daily Volume
Avg Daily Volume:	1.65M
Avg Daily Volume (30 D):	2.07M
Avg Daily Volume (90 D):	2.81M

Trade Size
Avg Trade Size (Sh.):	205
Avg Trade Size (Sh.) (30 D):	125
Avg Trade Size (Sh.) (90 D):	140

Institutional Trades
Total Institutional Trades:	554
Avg Institutional Trade:	$1.92M
Avg Institutional Trade (30 D):	$1.67M
Avg Institutional Trade (90 D):	$1.85M
Avg Institutional Trade Volume:	.56M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.4M
Avg Closing Trade (30 D):	$1.69M
Avg Closing Trade (90 D):	$2.05M
Avg Closing Volume:	623.94K

News

Feb 6, 2026 @ 1:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: Na

Oct 17, 2025 @ 1:00 PM Sandhoff Disease Treatment Market Size Projects US... Source: Towards Healthcare

Sep 5, 2025 @ 12:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: Hayleigh Collins

Aug 1, 2025 @ 9:06 PM Taysha Gene Therapies Announces Inducement Grant U... Source: Hayleigh Collins

Jun 3, 2025 @ 9:17 PM Taysha Gene Therapies Announces Details for Oral P... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.33	$-.09	$-.09
Diluted EPS	$-.33	$-.09	$-.09
Revenue	$6.31M	$M	$1.99M
Gross Profit
Net Income / Loss	$-99.93M	$-32.73M	$-26.88M
Operating Income / Loss	$-102.13M	$-34.02M	$-26.75M
Cost of Revenue
Net Cash Flow	$139.66M	$-15.42M	$196.17M
PE Ratio